Skip to main content
Have a personal or library account? Click to login
The Analysis of Risk Factors and Clinical-Demographic Characteristics of Patients with Clostridium Dificille Infection as Well as The Outcome of Their Treatment Cover

The Analysis of Risk Factors and Clinical-Demographic Characteristics of Patients with Clostridium Dificille Infection as Well as The Outcome of Their Treatment

EABR. Experimental and Applied Biomedical Research
Volume 17 (2016): Issue 2 (June 2016)
By: ,  ,  ,  ,   and    
Open Access
|Jun 2016
References

References

  1. 1. Moudgal V, Sobel JD. Clostridium difficile colitis: a review. Hosp Pract (1995). 2012; 40(1): 139-48.
    Open DOISearch in Google Scholar
  2. 2. Furuya-Kanamori L, Stone JC, Clark J, McKenzie SJ, Yakob L et al. Comorbidities, Exposure to Medications, and the Risk of Community-Acquired Clostridium difficile Infection: a systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2015; 36(2): 132-41.
    Open DOISearch in Google Scholar
  3. 3. Gao T, He B, Pan Y, Deng Q, Sun H et al. Association of Clostridium difficile infection in hospital mortality: A systematic review and meta-analysis. Am J Infect Control. 2015; 43(12): 1316-20.
    Open DOISearch in Google Scholar
  4. 4. Goodhand JR, Alazawi W, Rampton D. Systematic review: Clostridium difficile and inflammatory bowel disease. Aliment Pharmacol Ther. 2011; 33(4): 428-41.
    Open DOISearch in Google Scholar
  5. 5. Bavishi C, DuPont HL. Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection. Alimen Pharmacol Ther 2011; 34: 1269-81.
    Open DOISearch in Google Scholar
  6. 6. Kwok CS, Arthur AK, Anibueze CI, Singh S, Cavallazzi R et al. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am J Gastroenterol. 2012; 107(7): 1011-9.
    Open DOISearch in Google Scholar
  7. 7. Janarthanan S, Ditah I, Adler DG, Ehrinpreis MN. Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis. Am J Gastroenterol. 2012; 107: 1001-10.
    Open DOISearch in Google Scholar
  8. 8. Bauer MP, Notermans DW, van Benthem BH, Brazier JS, Wilcox MH еt al. Clostridium difficile infection in Europe: a hospital-based survey. Lancet. 2011; 377(9759): 63-73.
    Open DOISearch in Google Scholar
  9. 9. Surowiec D, Kuyumjian AG, Wynd MA, Cicogna CE. Past, present, and future therapies for Clostridium difficile-associated disease. Ann Pharmacother 2006; 40: 2155 - 63.
    Open DOISearch in Google Scholar
  10. 10. Deshpande A, Pasupuleti V, Thota P, Pant C, Rolston DD et al. Community-associated Clostridium difficile infection and antibiotics: a meta-analysis. J Antimicrob Chemother. 2013; 68(9): 1951-61.
    Open DOISearch in Google Scholar
  11. 11. Brown KA, Khanafer N, Daneman N, Fisman DN. Meta- analysis of antibiotics and the risk of communityassociated Clostridium difficile infection. Antimicrob Agents Chemother. 2013; 57(5): 2326-32.
    Open DOISearch in Google Scholar
  12. 12. Dial S, Alrasadi K, Manoukian C, Huang A, Menzies D. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies. CMAJ. 2004; 171: 33-8.
    Open DOISearch in Google Scholar
  13. 13. Kelly CP, LaMont JT. Clostridium difficile-more difficult than ever. N Engl J Med. 2008; 359(18): 1932-40.
    Open DOISearch in Google Scholar
  14. 14. Tang-Feldman Y, Mayo S, Silva J Jr et al. Molecular аnalysis of Clostridium difficile strains isolated from 18 cases of recurrent Clostridium difficile-associated diarrhea. J Clin Microbiology 2003; 41: 3413-4.
    Open DOISearch in Google Scholar
  15. 15. Hookman P, Barkin JS. Clostridium difficile associated infection, diarrhea and colitis. World J Gastroenterol 2009; 15: 1554-80.
    Open DOISearch in Google Scholar
  16. 16. Arvand M, Hauri AM, Zaiss NH, Witte W, Bettge- Weller G. Epidemiology of severe Clostridium difficile infections in Hesse, Germany in 2008-2009. Dtsch Med Wochenschr 2010; 135(40): 1963-7.
    Open DOISearch in Google Scholar
  17. 17. Goodhand JR, Alazawi W, Rampton D. Systematic review: Clostridium difficile and inflammatory bowel disease. Aliment Pharmacol Ther 2011; 33(4): 428-41.
    Open DOISearch in Google Scholar
  18. 18. Bajaj JS, O’Leary JG, Reddy KR, Wong F, Olson JC et al. Second infections inde-pendently increase mortality in hospitalized patients with cirrhosis: the North American сonsortium for the study of end-stage liver disease (NACSELD) experience. Hepatology 2012; 56(6): 2328-35.
    Open DOISearch in Google Scholar
  19. 19. Di X, Bai N, Zhang X, Liu B, Ni W et al. A meta-analysis of metronidazole and vancomycin for the treatment of Clostridium difficile infection, stratified by disease severity. Braz J Infect Dis. 2015; 19(4):339-49
    Open DOISearch in Google Scholar
  20. 20. Shafran DM, Shafran SD. Treating Clostridium difficile infection. CMAJ. 2014;186: 7.
    Search in Google Scholar
DOI: https://doi.org/10.1515/sjecr-2016-0032 | Journal eISSN: 2956-2090 (formerly 2335-075X, 2956-0454) | Journal ISSN: 2956-0454 (formerly 1820-8665)
Journal RSS Feed
Language: English
Page range: 139 - 144
Submitted on: Feb 5, 2016
Accepted on: Feb 24, 2016
Published on: Jun 10, 2016
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Keywords:
Clostridium difficile,
diarrhoea,
antibiotics,
proton pump inhibitors,
metronidazole,
vancomycin
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2016 Ivana Raković, Biljana Popovska Jovicic, Andriana Bukonjic, Sara Petrovic, Petar Canovic, Nedim Hamzagic, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 17 (2016): Issue 2 (June 2016)
Previous article
Next article